Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation

Cheryl L. Neudauer, James B. McCarthy

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Dysregulated signaling contributes to altered cellular growth, motility, and survival during cancer progression. We have evaluated the ability of several factors to stimulate migration in WM1341D, a cell line derived from an invasive human vertical growth phase melanoma. Basic fibroblast growth factor, hepatocyte growth factor, interleukin-8, and CCL27 each slightly increased migration. Insulin-like growth factor I (IGF-I), however, stimulated a 15-fold increase in migration. This response required the IGF-I receptor, which activates phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathways. Both pathways have been implicated in migration in a variety of cell types, but the signaling required for IGF-I-induced melanoma cell migration is not well defined. IGF-I-stimulated activation of MAPK/ERK signaling in WM1341D cells was inhibited by U0126, but a 33-fold higher dose of U0126 was needed to inhibit IGF-I-stimulated cellular migration. In contrast, similar concentrations of either wortmannin or LY294002 were required to inhibit both IGF-I-induced PI3K activation and migration. These results indicate that IGF-I-stimulated migration of WM1341D cells requires PI3K activation but is independent of MAPK/ERK signaling. Determining the contributions of IGF-I signaling pathways to migration will help us to understand melanoma progression and may lead to new therapeutic targets of this highly metastatic cancer.

Original languageEnglish (US)
Pages (from-to)128-137
Number of pages10
JournalExperimental Cell Research
Issue number1
StatePublished - May 15 2003

Bibliographical note

Funding Information:
We thank Dr. Meenhard Herlyn at The Wistar Institute for the WM1341D human melanoma cells. We also thank Dr. Yun Qiu and Dr. Julie Vrana for helpful discussions and Dr. Melanie Simpson and Dr. Kelli Bullard for careful review of the data and the manuscript. This work was supported by Grant CA82295 from the National Institutes of Health (to J.B.M.)


  • Insulin-like growth factor I
  • Melanoma
  • Migration
  • Mitogen-activated protein kinase/extracellular-regulated kinase
  • Phosphoinoinositide 3-kinase
  • Signaling


Dive into the research topics of 'Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation'. Together they form a unique fingerprint.

Cite this